Aligos Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of ALGS for the last quarter is 1.27 M USD, and it's 19.60% higher compared to the previous quarter. The net income of Q3 24 is -19.26 M USD.